WASHINGTON — In this Healio Video Perspective from the American Society of Cataract and Refractive Surgery meeting, James A. Katz, MD, discusses dry eye research that focuses on a patient’s overall well-being rather than just one eye.
Katz said that for a patient to feel better overall, both eyes should be treated. In a study with nearly 900 participants, Tyrvaya (varenicline solution, Oyster Point Pharma) showed significant improvement in mean Schirmer test score as well as clinically significant improvement in the fellow eye.